China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

Discover how U.S. biotechs can learn from China's success in affordable, high-quality drug development. Read more here.

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

The sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock ...

Recent federal actions could derail decades of progress. Meanwhile China has prioritized investment in biotech.

China's biotechnology sector is experiencing notable growth, with the ChinaAMC Hang Seng Biotech ETF, tracking the Hang Seng ...

China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds ...

The recent uptick in the performance of A-share and Hong Kong-listed biotech stocks, particularly those related to innovative drugs, mirrors the trend toward a faster internationalization of China's ...

Photo: Qu Dacheng, Vice Mayor of Chaoyang District, delivers remarks at the Global Investment Cooperation Trends Forum ...

According to the Nature Index, China now leads the U.S. in physics and chemistry publications.

Citing “a substantial rise in trade barriers’’ but without mentioning Trump by name, the 189-country lender predicted that ...

Some of China's top beauty brands such as Proya and S'Young are exploring acquisitions of smaller foreign rivals to expand ...